Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Brändlein

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Molecular Cancer|December 7, 2007
Tumors: too sweet to remember?H Peter Vollmers, Stephanie Brändlein
Advanced Drug Delivery Reviews|July 6, 2006
Natural IgM antibodies: the orphaned molecules in immune surveillanceH Peter Vollmers, Stephanie Brändlein
New Biotechnology|May 16, 2009
Natural antibodies and cancerH Peter Vollmers, Stephanie Brändlein
Journal of Autoimmunity|September 11, 2007
Natural antibodies and cancerH Peter Vollmers, Stephanie Brändlein
Human Antibodies|May 31, 2003
Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodiesH Peter Vollmers, Stephanie Brändlein
Recent Patents on Anti-Cancer Drug Discovery|June 10, 2008
Natural monoclonal antibodies and cancerPeter H Vollmers, Stephanie Brändlein
Immunotherapy|July 20, 2010
Natural human immunoglobulins in cancer immunotherapyH Peter Vollmers, Stephanie Brändlein
Melanoma Research|June 4, 2013
Early development of PAT-SM6 for the treatment of melanomaFrank Hensel, Miriam Eckstein, Andreas Rosenwald, et al.
Cancer Research|January 6, 2010
Diagnostic and therapeutic potential of a human antibody cloned from a cancer patient that binds to a tumor-specific variant of transcription factor TAF15Nicole Schatz, Stephanie Brändlein, Kilian Rückl, et al.
Cancer Research|June 3, 2004
Lipoptosis: tumor-specific cell death by antibody-induced intracellular lipid accumulationTina Pohle, Stephanie Brändlein, Nele Ruoff, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Molecular Cancer|December 7, 2007
Tumors: too sweet to remember?H Peter Vollmers, Stephanie Brändlein
Advanced Drug Delivery Reviews|July 6, 2006
Natural IgM antibodies: the orphaned molecules in immune surveillanceH Peter Vollmers, Stephanie Brändlein
New Biotechnology|May 16, 2009
Natural antibodies and cancerH Peter Vollmers, Stephanie Brändlein
Journal of Autoimmunity|September 11, 2007
Natural antibodies and cancerH Peter Vollmers, Stephanie Brändlein
Human Antibodies|May 31, 2003
Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodiesH Peter Vollmers, Stephanie Brändlein
Recent Patents on Anti-Cancer Drug Discovery|June 10, 2008
Natural monoclonal antibodies and cancerPeter H Vollmers, Stephanie Brändlein
Immunotherapy|July 20, 2010
Natural human immunoglobulins in cancer immunotherapyH Peter Vollmers, Stephanie Brändlein
Melanoma Research|June 4, 2013
Early development of PAT-SM6 for the treatment of melanomaFrank Hensel, Miriam Eckstein, Andreas Rosenwald, et al.
Cancer Research|January 6, 2010
Diagnostic and therapeutic potential of a human antibody cloned from a cancer patient that binds to a tumor-specific variant of transcription factor TAF15Nicole Schatz, Stephanie Brändlein, Kilian Rückl, et al.
Cancer Research|June 3, 2004
Lipoptosis: tumor-specific cell death by antibody-induced intracellular lipid accumulationTina Pohle, Stephanie Brändlein, Nele Ruoff, et al.
Pageof 4